NEW YORK--(BUSINESS WIRE)-- Neurogene Inc. (NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results